Conatus Pharma to explore options as liver disease drug fails trial

52

Conatus Pharmaceuticals Inc said on Monday it plans to explore options and implement a restructuring plan after its liver disease drug failed in a mid-stage trial.

http://feeds.reuters.com/~r/reuters/healthNews/~3/juiqBtG1RUE/conatus-pharma-to-explore-options-as-liver-disease-drug-fails-trial-idUSKCN1TP2NA

- Advertisement -